FDA Considers Penalizing Sponsors Using Unregistered IRBs, Solicits Input
This article was originally published in The Gray Sheet
Executive Summary
FDA and HHS' Office for Human Research Protections are proposing establishment of a designated Internet site for registration of IRBs